ITM PASSION FOR PRECISION

Live / Registered — Registered (as of 02 Nov 2021)

What this means for you

Registered since 02 Nov 2021. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number
90447337
Registration number
6546779
Mark type
Design + words
Filed
04 Jan 2021
Published for opposition
17 Aug 2021
Registered
02 Nov 2021
Attorney of record
Kari Moyer-Henry

Goods and services

  • Class 005 — Pharmaceuticals: Radiopharmaceutical diagnostic and therapeutic preparations for medical purposes, in particular radiopharmaceutical preparations for endo-radionuclide therapy, brachytherapy and radiopharmaceutical preparations for positron emission tomography (PET) or single photon emission tomography (SPECT), target radionuclide and peptide receptor radionuclide therapy (PRRT); theranostics in the field of precision oncology; radiopharmaceutical products, namely, lutetium-containing precursors; solutions for radioactive labelling; radiopharmaceutical preparations for use in oncology, namely, radiopharmaceuticals containing radioisotopes, e.g. lutetium-177, actinium-225, yttrium-90 for treatment and radioisotopes such as gallium-68 or fluorine-18 for diagnosis of tumors; target radiopharmaceuticals containing a target molecule, e.g. peptide or antibody, depending on the indication and a medical radioactive isotope; radiopharmaceuticals containing gallium and its complexes, gallium-68 DOTATOC; 177Lu-edotreotide preparations for targeted radionuclide therapy in patients with neuroendocrine tumors of gastroenteric or pancreatic origin (GEP-NET); radiopharmaceuticals for use in the therapy of GEP-NET, osteosarcoma, bone metastases, prostate cancer, breast cancer, brain cancer, ovarian cancer; radiopharmaceuticals containing radioisotopes with short half-lives, such as gallium-68 or fluorine-18 for diagnostic applications; radiopharmaceuticals for use with high-sensitivity molecular imaging technologies such as PET (positron emission tomography) or SPECT (single photon emission tomography), for imaging organs and lesions and for early diagnosis of diseases; radiopharmaceuticals containing medical radioisotopes with longer half-lives, in particular lutetium-177, actinium-225 or yttrium-90 for the treatment of tumor diseases
  • Class 010 — Medical apparatus: Medical instruments, apparatus and containers for the application of radiopharmaceutical and radiodiagnostic preparations; control, regulating and measuring apparatus as parts of medical instruments, apparatus and containers included in this class, in particular apparatus for therapy and diagnosis with a radiotherapeutic or radiodiagnostic substance; radionuclide generators for radiopharmaceutical purposes
  • Class 042 — Scientific and technological services: Conducting clinical trials in all stages and with various indications, particularly in oncology; conducting phase III clinical trials with target radiopharmaceutical 177Lu-Edotreotide in patients with neuroendocrine tumours of gastroenteric or pancreatic origin (GEP-NET)
  • Class 044 — Medical, beauty and agricultural services: Medical services, in particular services in the field of radiotherapeutic and radiodiagnostic oncology, cardiology, angiology, neuroradiology and nuclear medicine and brachytherapy, including intercavitary, interstitial and intravascular brachytherapy, radionuclide labelling, PET and SPECT scanning and target radionuclide therapy, peptide receptor radionuclide therapy (PRRT), personal nuclear medicine and precision oncology

Owner

Prior registrations

Prosecution history

  • 19 May 2022 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
  • 02 Nov 2021 — REGISTERED-PRINCIPAL REGISTER
  • 17 Aug 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
  • 17 Aug 2021 — PUBLISHED FOR OPPOSITION
  • 28 Jul 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
  • 13 Jul 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
  • 12 Jul 2021 — ASSIGNED TO EXAMINER
  • 03 Apr 2021 — NOTICE OF DESIGN SEARCH CODE E-MAILED
  • 02 Apr 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
  • 28 Jan 2021 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
  • 28 Jan 2021 — TEAS VOLUNTARY AMENDMENT RECEIVED
  • 07 Jan 2021 — NEW APPLICATION ENTERED

View this trademark record on Marksy